Marie Warrer Munch (@marie_warrer) 's Twitter Profile
Marie Warrer Munch

@marie_warrer

MD, ph.d.-student, Intensive Care Unit, Rigshospitalet
Coordinating investigator of COVID STEROID 2 trial

ID: 1004647780835610624

calendar_today07-06-2018 08:54:31

14 Tweet

70 Followers

57 Following

CRIC (@cric_int_care) 's Twitter Profile Photo

Congratulations Hvidovre in Denmark. This is the second site in Denmark enrolling patients in the COVID STEROID 2 trial. Nine patients enrolled, 991 to go. #COVIDSTEROID2 Thomas Benfield Klaus Tjelle @AndersPerner Marie Warrer Petersen

CRIC (@cric_int_care) 's Twitter Profile Photo

Congratulations, to Kolding ICU, Aalborg ICU and Hvidovre Infectious Diseases for randomisering their first patients to the COVID STEROID 2 trial assessing higher vs. lower doses of dexamethasone in patients with COVID-19 and severe hypoxia #IntensiveCareTrial #COVIDSTEROID2

CRIC (@cric_int_care) 's Twitter Profile Photo

Now 6 Danish sites and 2 Indian sites have enrolled 23 patients into the COVID STEROID 2 trial. The latest site to enroll patients is the ICU in Køge (Denmark) - great job Lone Musaeus Poulsen. #IntensiveCareTrial #COVIDSTEROID2 @AndersPerner Marie Warrer Petersen

CRIC (@cric_int_care) 's Twitter Profile Photo

Congratulations to Hillerød and Odense ICUs for randomising their first patients into the COVID STEROID 2 trial. 28 out of 1,000 patients with COVID-19 have now been randomised to higher or lower doses of dexamethasone at 8 Danish and 2 Indian sites Morten Bestle #COVIDSTEROID2

CRIC (@cric_int_care) 's Twitter Profile Photo

Amazing last hours for the COVID STEROID 2 trial - 15 patients enrolled! Thanks to all sites, especially thanks to the two new sites Rajendra Institute of Medical Sciences, Ranchi, India and Thoracic ICU, Rigshospitalet, Denmark. #COVIDSTEROID2 @AndersPerner Marie Warrer Petersen Maj-Brit N Kjær

CRIC (@cric_int_care) 's Twitter Profile Photo

Congratulations to S.L. Raheja Fortis Hospital in India for randomizing their first patient to the COVID STEROID 2 trial. 76 patients enrolled and 924 to go before gaining knowledge on lower vs. higher dose of Dexamethasone for COVID-19 patients with hypoxia #COVIDSTEROID2

CRIC (@cric_int_care) 's Twitter Profile Photo

Congratulations to all investigators for reaching a new milestone in the COVID STEROID 2 trial: patient no. 200 has just been randomised at Herlev ICU, Denmark. The trial is now recruiting from 11 Danish, 8 Indian and 1 Swiss site. More sites to join soon. #COVIDSTEROID2

CRIC (@cric_int_care) 's Twitter Profile Photo

The #COVID_STEROID_2 has enrolled 321/1000, thanks to all investigators for taking the time to help improve the care of COVID-19 patients during this pandemic! Welcome to Respiratory Medicine at Hvidovre/DK and Slagelse/DK, who enrolled their first patient💪 Happy New Year 🥳🍾🥂

Marie Warrer Munch (@marie_warrer) 's Twitter Profile Photo

The COVID STEROID 2 trial results out now. A huge thanks to everyone involved in the trial. Amazing team effort getting here 🇩🇰🇮🇳🇸🇪🇨🇭 Also a BIG thanks to Critical Care Reviews for hosting a great panel discussion of the trial results last night.

Intensive Care Medicine (@youricm) 's Twitter Profile Photo

Dexamethasone in #COVID19 & severe hypoxaemia: with 12 vs 6 mg 💉high probabilities of benefit on all outcomes, including days alive without life support/mortality 💉relatively low probabilities of important harm COVID STEROID 2 trial bayesian analysis bit.ly/3kqnOgp

Dexamethasone in #COVID19 & severe hypoxaemia: with 12 vs 6 mg
💉high probabilities of benefit on all outcomes, including days alive without life support/mortality
💉relatively low probabilities of important harm 
COVID STEROID 2 trial bayesian analysis
bit.ly/3kqnOgp